Antti Jylhä Selected Research

1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)

1/2020

Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antti Jylhä Research Topics

Disease

3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2020
3	Inflammation (Inflammations) 12/2021 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2020
2	Heart Failure 09/2021 - 01/2020
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2020
2	Glaucoma 01/2018 - 01/2018
1	Myocardial Infarction 01/2022
1	Stroke (Strokes) 01/2022
1	Atherosclerosis 12/2021
1	Type 2 Diabetes Mellitus (MODY) 12/2021
1	Atrial Fibrillation 09/2021
1	Rheumatoid Arthritis 09/2021
1	Ovarian Neoplasms (Ovarian Cancer) 04/2021
1	Neoplasms (Cancer) 04/2021
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Necrosis 01/2020
1	Strabismus (Squint) 01/2019
1	Hyperemia 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Retinal Vein Occlusion 01/2018
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2018
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Retinal Degeneration 01/2017

Drug/Important Bio-Agent (IBA)

6	CeramidesIBA 01/2022 - 01/2020
4	LipidsIBA 12/2021 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
2	Phosphatidylcholines (Phosphatidylcholine)IBA 12/2021 - 01/2020
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2018
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	CholesterolIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 12/2021
1	Apolipoprotein C-IIIIBA 12/2021
1	Coffee FDA Link 09/2021
1	AntigensIBA 04/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020
1	LDL CholesterolIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	darapladibIBA 01/2020
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2020
1	tear proteinsIBA 01/2019
1	FilaminsIBA 01/2018
1	Crystallins (Crystallin)IBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	SteroidsIBA 01/2018
1	Latanoprost (Xalatan)FDA Link 01/2018
1	ProteomeIBA 01/2018
1	Nonmuscle Myosin Type IIAIBA 01/2018
1	tafluprostIBA 01/2018
1	Fluorometholone (FML)FDA Link 01/2018

Therapy/Procedure

1	Therapeutics 01/2020
1	Refractive Surgical Procedures 01/2019
1	Castration 01/2018